Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • RFK Jr.’s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

WHAT'S NEW

  • RFK Jr.'s Future
  • Melanoma Drug
  • Charity Care Gap
  • Search for New FDA Chief

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Sep 18 2024

Full Issue

Express Scripts Sues FTC, Calls Report About Drug Middlemen 'Erroneous'

Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.

Bloomberg: Cigna Sues US Federal Trade Commission Over ‘Defamatory’ Report

Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes pharmacy benefit managers and asked the court to order the agency to retract it. The lawsuit escalates the conflict between drug middlemen and one of the top US antitrust enforcers, which has been scrutinizing the industry. Cigna’s Express Scripts unit called the FTC’s July report “unfair, biased, erroneous, and defamatory” in a lawsuit filed Tuesday in federal court in Missouri. (Tozzi, 9/17)

KFF Health News: California May Regulate And Restrict Pharmaceutical Brokers 

California Gov. Gavin Newsom will soon decide whether the most populous U.S. state will join 25 others in regulating the middlemen known as pharmacy benefit managers, or PBMs, whom many policymakers blame for the soaring cost of prescription drugs. PBMs have been under fire for years for alleged profiteering and anticompetitive conduct, but efforts to regulate the industry at the federal level have stalled in Congress. (Thompson, 9/18)

Benefits Pro: Employers Need To Stop Maximizing PBM Drug Plan Rebates, Says Mark Cuban

Cuban, the founder of the Mark Cuban Cost Plus Drug mail-order pharmacy, said the main rebate funding mechanism is the sick employee, in a recent webinar. (Bell, 9/17)

Stat: U.S. Agency Threatens J&J With Sanctions If It Switches Payments To 340B Hospitals

A U.S. government agency has threatened Johnson & Johnson with sanctions if the company proceeds with plans to alter payment methods for some hospitals that participate in a federal drug discount program. In a letter sent on Tuesday, the U.S. Health Resources and Services Administration maintained that a J&J plan to issue rebates for two widely prescribed medicines instead of offering discounted prices would violate federal law. (Silverman, 9/17)

Franklin County Free Press: Capital Blue Cross Aids Employers In Managing Soaring Prescription Costs 

According to Capital Blue Cross, the integration of prescription drug coverage with medical plans is key in managing healthcare costs effectively. With nearly half of Americans on at least one prescription and a quarter on three or more, as reported by the Centers for Disease Control and Prevention (CDC), the financial impact on both employees and employers is significant. (9/17)

Iowa News Service: Prescription Costs Soon To Be Capped For Iowa Seniors 

A new report from A-A-R-P Iowa predicts thousands of seniors on Medicare ‘Part D’ in the state will save money on their prescriptions, thanks to a cap on out-of-pocket expenses set to take effect next year. (9/16)

Stat: How Drugmakers Rely On ‘Use Codes’ To Vastly Expand Their Patent Claims

Amid debate over potential abuse of the U.S. patent system by the pharmaceutical industry, moves by some drugmakers to expand their patent claims appear to be delaying the arrival of lower-cost generic medicines to the marketplace, according to a STAT analysis. (Silverman and Nolan, 9/18)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 15
  • Thursday, May 14
  • Wednesday, May 13
  • Tuesday, May 12
  • Monday, May 11
  • Friday, May 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF